This updated Medicines Q & A reviews the evidence available and considers when prophylactic doses of low molecular weight heparins can be used in patients…
A UKMi Product Safety assessment on Zalviso® (sufentanil citrate) sublingual tablets which describes the in-use medication safety considerations resultant from the product’s presentation or other…
There is a potential 6 month supply issue affecting abciximab from October through till March 2018. This memo advises on alternative treatment options in the…
On the basis of biblical statements, Jehovah’s Witnesses decline the transfusion of whole blood, red cells, white cells, plasma and platelets. This Medicines Q&A discusses…
Esmya (ulipristal acetate 5mg tablets) was launched in April 2012 for pre-operative treatment of moderate to severe symptoms of uterine fibroids in women of reproductive…
Based on the pharmacokinetics and pharmacodynamics of individual herbal medicines the recommendations for discontinuation vary between 24 hours and 2 weeks. It is generally advised…
Bariatric surgery may impact on the absorption and side effect profile of some medicines. Although this is a growing area, primary information in the field…
Pfizer, as the sole licensed supplier, is currently experiencing supply problems with Ketalar 10mg/ml in the UK. The 10mg/ml is anticipated to be out of…